NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » NewsRoom » NewsRoom Articles
TuesdayMar 14, 2017 12:00 pm

LeMaitre Vascular, Inc. (NASDAQ: LMAT) Starts Presentation at 29th Annual Roth Conference

LeMaitre Vascular (NASDAQ: LMAT) develops, manufactures and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shunt blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable less invasive removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins, and occlusion catheters that temporarily occlude blood flow. For more information, visit the…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

Lonestar Resources US, Inc. (NASDAQ: LONE) Starts Presentation at 29th Annual Roth Conference

Lonestar Resources (NASDAQ: LONE) is an independent oil and gas company that engages in the acquisition, development and production of unconventional resources in the United States. The company primarily focuses on Eagle Ford Shale properties that cover an area of 35,000 net acres in Texas counties. It also holds interests in an early-stage project in the Bakken Petroleum System that covers an area of 34,163 net acres in the Bakken, Three Forks, and Lower Lodgepole formations located in the Roosevelt County, Montana. The company is based in Fort Worth, Texas. For more information, visit the company’s website at www.lonestarresources.com. About…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

NeuroDerm Ltd. (NASDAQ: NDRM) Starts Presentation at 29th Annual Roth Conference

NeuroDerm (NASDAQ: NDRM) is a clinical-stage pharmaceutical company that engages in developing products for the treatment of central nervous system (CNS) disorders. The company’s product candidates, which have completed phase IIa clinical trial, include ND0612H for the treatment of patients with severe Parkinson’s disease; and ND0612L for the treatment of patients with moderate stage of Parkinson's disease. It is also developing ND0801, which is in phase IIa clinical trial for the treatment of cognition disorders associated with CNS diseases, such as ADD/ADHD, Alzheimer’s disease, and schizophrenia; and ND0701, an apomorphine-based product candidate for the treatment of moderate to severe Parkinson’s…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

Capricor Therapeutics, Inc. (NASDAQ: CAPR) Starts Presentation at 29th Annual ROTH Conference

Capricor Therapeutics (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other medical conditions. The company’s lead candidate, CAP-1002, is a cardiac cell therapy that is currently being evaluated for the treatment of heart disease associated with Duchenne muscular dystrophy and myocardial infarction (heart attack). Capricor is exploring the use of CAP-2003, its exosome product candidate in various therapeutic areas including the treatment of ophthalmic disorders.  For more information, visit the company’s website at www.capricor.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

Uniroyal Global Engineered Products (UNIR) Starts Presentation at 29th Annual Roth Conference

Uniroyal Global Engineered Products (OTCQB: UNIR) develops, manufactures and distributes vinyl coated fabrics products that have applications in the automotive and non-automotive transportation, indoor/outdoor furniture, commercial and hospitality seating, healthcare facilities, athletic equipment, and residential primarily in North America and Europe. The company’s products in the automotive industry are used primarily in seating, door panels, head and arm rests, security shades, and trim components. Its non-automotive applications include outdoor seating for utility and sports vehicles; and sheeting used in medical, nuclear protection, personal protection, moisture barriers, pram and nursery, movie screen, and decorative surface applications. For more information, visit the…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

Ormat Technologies, Inc. (NYSE: ORA) Starts Presentation at 29th Annual Roth Conference

Ormat Technologies (NYSE: ORA) engages in the geothermal and recovered energy power business worldwide. The Electricity segment develops, builds, owns and operates geothermal and recovered energy-based power plants; and sells electricity. Ormat’s Product segment designs, manufactures and sells equipment for geothermal and recovered energy-based electricity generation, including fossil fuel powered turbo-generators and heavy duty direct-current generators. It also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal and recovered energy-based power plants. For more information, visit the company’s website at www.ormat.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

Knowles Corp. (NYSE: KN) Starts Presentation at 29th Annual Roth Conference

Knowles (NYSE: KN) is a global supplier of advanced micro-acoustic, audio processing, and specialty component solutions, serving the mobile consumer electronics, communications, medical, military, aerospace, and industrial markets. Knowles uses its position in MEMS (micro-electro-mechanical systems) microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in smartphones, tablets, and wearables. The company’s focus on the customer, combined with unique technology, proprietary manufacturing techniques, rigorous testing and global scale, enables it to deliver innovative solutions that optimize the user experience. For more information, visit the company’s website at www.knowles.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

Continue Reading

TuesdayMar 14, 2017 12:00 pm

Ellie Mae, Inc. (NYSE: ELLI) Starts Presentation at 29th Annual ROTH Conference

Ellie Mae (NYSE: ELLI) is a provider of innovative on-demand software solutions and services for the residential mortgage industry. Mortgage lenders of all sizes use Ellie Mae’s Encompass® all-in-one mortgage management solution, Mavent Compliance Service, and AllRegs research, reference and education resources to improve compliance, loan quality and efficiency across the entire mortgage lifecycle. For more information, visit the company’s website at www.elliemae.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers,…

Continue Reading

TuesdayMar 14, 2017 11:30 am

Akoustis Technologies, Inc. (AKTS) Starts Presentation at 29th Annual ROTH Conference

Akoustis Technologies (OTC: AKTS) operates in the telecommunications and fiber optics sector where it designs and manufactures various radio frequency (RF) filters enabling the RF front-end of mobile wireless devices, such as smartphones and tablets. Akoustis focuses on manufacturing and commercializing its patent-pending Bulk ONE acoustic wave technology to address the frequency-selectivity requirements in mobile smartphones, enhancing the efficiency and signal quality of mobile wireless devices and enabling The Internet of Things.  For more information, visit the company’s website at www.akoustis.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication…

Continue Reading

TuesdayMar 14, 2017 11:30 am

Applied Genetic Technologies Corp. (NASDAQ: AGTC) Starts Presentation at 29th Annual ROTH Conference

Applied Genetic Technologies (NASDAQ: AGTC) is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed to transform the lives of patients with severe diseases, with an initial focus in ophthalmology. AGTC's lead product candidates are designed to treat inherited orphan diseases of the eye, caused by mutations in single genes that significantly affect visual function and currently lack effective medical treatments. AGTC's product pipeline includes ophthalmology programs in X-linked retinoschisis (XLRS), X-linked retinitis pigmentosa (XLRP), achromatopsia, wet age-related macular degeneration, and our optogenetics program with Bionic Sight. AGTC's non-ophthalmology programs include its adrenoleukodystrophy program…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

NetworkNewsWire is powered by IBNAi

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers